Article
siRNA knocks down Hsp27 and increases angiotensin II-induced phosphorylated NF-kappaB p65 levels in aortic smooth muscle cells.
Department of Anatomy & Neurobiology, Faculty of Medicine, Dalhousie University, Halifax, NS B3H 1X5, Canada.
Agents and Actions (impact factor:
1.59).
04/2009;
58(6):336-43.
DOI:10.1007/s00011-009-8166-2
pp.336-43
Source: PubMed
-
Citations (0)
- Cited In (1)
-
Article: Flavaglines alleviate doxorubicin cardiotoxicity: implication of Hsp27.
[show abstract] [hide abstract]
ABSTRACT: Despite its effectiveness in the treatment of various cancers, the use of doxorubicin is limited by a potentially fatal cardiomyopathy. Prevention of this cardiotoxicity remains a critical issue in clinical oncology. We hypothesized that flavaglines, a family of natural compounds that display potent neuroprotective effects, may also alleviate doxorubicin-induced cardiotoxicity. Our in vitro data established that a pretreatment with flavaglines significantly increased viability of doxorubicin-injured H9c2 cardiomyocytes as demonstrated by annexin V, TUNEL and active caspase-3 assays. We demonstrated also that phosphorylation of the small heat shock protein Hsp27 is involved in the mechanism by which flavaglines display their cardioprotective effect. Furthermore, knocking-down Hsp27 in H9c2 cardiomyocytes completely reversed this cardioprotection. Administration of our lead compound (FL3) to mice attenuated cardiomyocyte apoptosis and cardiac fibrosis, as reflected by a 50% decrease of mortality. These results suggest a prophylactic potential of flavaglines to prevent doxorubicin-induced cardiac toxicity.PLoS ONE 01/2011; 6(10):e25302. · 4.09 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
A10 cells
Ang II
Ang II-induced NF-kappaB signaling pathway
Ang II-induced phosphorylated p65
Ang II-induced signaling pathway
Angiotensin II
Heat shock
heat shock proteins
Hsp27 levels
Hsp27 siRNA
immunofluorescence microscopy
inhibitor kappaB-alpha
p65 phosphorylation
p65 subunit
proinflammatory effects
proinflammatory nuclear factor kappaB
rat aortic vascular smooth muscle
specific Hsps
vascular smooth muscle cells
Western analysis